NETHERLANDS – Royal Philips, a global leader in health technology, today announced the launch of its digital experience during the virtual European Society of Cardiology (ESC) 2021 Congress.
The company targets to showcase its latest suite of solutions to help improve outcomes for patients with cardiovascular disease by enabling quick, confident diagnoses, and efficient, effective treatments.
During the congress, Philips will demonstrate its continued leadership in cardiology across its integrated portfolio of solutions throughout the entire cardiac care journey, from early detection, diagnosis and treatment, to long-term follow-up.
Cardiovascular disease has become the number one healthcare challenge globally and is one of the leading causes of death worldwide. According to WHO, cardiovascular diseases claim an estimated 17.9 million lives each year.
More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age.
The costs associated with cardiovascular diseases are rising significantly, with an expected growth in cost of 101% by 2035. A report by ResearchandMarkets shows that the global cardiovascular drugs market is expected to grow from US$87.79 billion in 2020 to US$92.41 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%.
The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach US$107.77 billion in 2025 at a CAGR of 4%.
Definitive diagnostics, innovative procedures and personalized patient management are essential to help address these most challenging demands.
“From emergency care to diagnosis and treatment, to care into the home, cardiac care teams need the right information and support available at their fingertips across the entire cardiac patient journey,” said Bert van Meurs, Chief Business Leader of Image Guided Therapy at Philips.
Phillips will be showcasing; Philips Spectral CT 7500 for advanced cardiac imaging, New innovations in ultrasound which enhance clinical efficiency and diagnostic confidence, Improved workflow and patient focus in image guided procedures and Cardiology informatics solutions which drive actionable insights to enhance cardiology care.
Would you like to get regular updates of such news articles? Subscribe to our HealthCare Africa News, email newsletters, which provide the latest news insights from Africa and the World’s health, pharma and biotech industry. SUBSCRIBE HERE
